Clinical Trials Directory

Trials / Completed

CompletedNCT01176110

Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement

A Randomized Pilot Study for Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is known that perioperative hypothermia can influence the postoperative outcome negatively. The most important complications are cardiac, increased blood loss with need for transfusion and a significantly increased wound infection rate. The thermal redistribution after the induction of anesthesia is on of the reasons for perioperative hypothermia. Another reason is negative heat balance during surgery. Further negative side effects of hypothermia are an increase of blood viscosity and thus a higher risk for thrombosis, coagulopathy and thus an increased risk of bleeding. The aim of the study is to evaluate if patients with a perioperative active thermal management during an interventional minimal invasive valve replacement have a significantly higher body temperature at the end of the operation than patients without an active thermal management. Secondary outcome variables are complication rates, length of mechanical ventilation and length of ICU treatment.

Conditions

Interventions

TypeNameDescription
DEVICELMA Perfect TempThe LMA PerfecTemp™ patient warming system combines warming beneath the patient and advanced pressure reduction to combat hypothermia and decubitus ulcers. This device is used during the interventional minimal invasive valve replacement with unprecedented ease and safety

Timeline

Start date
2010-07-01
Primary completion
2011-03-01
Completion
2011-05-01
First posted
2010-08-05
Last updated
2011-05-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01176110. Inclusion in this directory is not an endorsement.